Thank you for correcting the text in this article. Your corrections improve Papers Past searches for everyone. See the latest corrections.

This article contains searchable text which was automatically generated and may contain errors. Join the community and correct any errors you spot to help us improve Papers Past.

Article image
Article image
Article image
Article image
Article image
Article image
Article image
Article image

Drug Trial In France

(Rec. 10 p.m.) PARIS, Nov. 15. Georges Feuillet, the 44-year-old inventor of the Stalinon drug alleged to have killed 102 persons and maimed others, sobbed yesterday: “I ask forgiveness.” when a Court president asked him if he had anything to say. The remainder of his reply was engulfed in sobs. The president then announced that judgment was reserved until December 19.

Feuillet is accused of involuntary homicide and of infringing pharmaceutical regulations. The maximum sentence is two years in prison on the first count and a £6OO fine on the second.

Also on trial in the fortnightlong hearing is Henri Genet, charged with infringing pharmaceutical regulations. Genet is the commercial director of the firm that made Stalinon—a drug composed of vitamin F and an organic salt of tin meant to cure boils and abscesses. Instead, it is alleged to have caused as many as 102 deaths. Many of the dead had brain tumours.

Permanent link to this item

https://paperspast.natlib.govt.nz/newspapers/CHP19571116.2.137

Bibliographic details

Press, Volume XCVI, Issue 28436, 16 November 1957, Page 13

Word Count
157

Drug Trial In France Press, Volume XCVI, Issue 28436, 16 November 1957, Page 13

Drug Trial In France Press, Volume XCVI, Issue 28436, 16 November 1957, Page 13

Help

Log in or create a Papers Past website account

Use your Papers Past website account to correct newspaper text.

By creating and using this account you agree to our terms of use.

Log in with RealMe®

If you’ve used a RealMe login somewhere else, you can use it here too. If you don’t already have a username and password, just click Log in and you can choose to create one.


Log in again to continue your work

Your session has expired.

Log in again with RealMe®


Alert